摘要

目的 探讨将心血管内科治疗方法用于冠心病心绞痛治疗中的效用价值。方法 研究中共选取126例患者作为实验对象，采取摇号方式将其分为对照与观察两个组别，均为63例患者，前者沿用常规治疗方法，后者在此基础上联合曲美他嗪以及舒血宁药物进行治疗，对比两组实际临床效果。结果 实验中数据表明，观察组患者在治疗后血脂水平明显优于对照组及治疗前，与此同时临床疗效显著提升（P＜0.05）。结论 对于冠心病心绞痛患者而言，曲美他嗪联合舒血宁药物治疗能够有效改善患者临床症状、减少患者发作频次、降低其血脂指标水，对促进患者康复效率的提升起到了积极促进作用。

关键词

冠心病；心绞痛；心血管内科治疗

Abstract

Objective: To explore the effectiveness and value of cardiovascular medical treatment in the treatment of coronary heart disease and angina pectoris.
Methods: A total of 126 patients were selected as experimental subjects in the study, and they were divided into control and observation groups by lottery method, both of which were 63 patients. The former continued to use conventional treatment methods, and the latter combined trimetazidine on this basis. And Shuxuening drug treatment, compare the actual clinical effect of the two groups.
Results: The data in the experiment showed that the blood lipid level of the observation group after treatment was significantly better than that of the control group and before treatment, and at the same time the clinical efficacy was significantly improved (P<0.05).
Conclusion  : For patients with coronary heart disease and angina pectoris, trimetazidine combined with Shuxuening drug therapy can effectively improve the clinical symptoms of patients, reduce the frequency of attacks, and reduce the level of blood lipid indicators, which has played a positive role in promoting the recovery efficiency of patients.

Key words

coronary heart disease; angina pectoris; cardiovascular medical treatment